Literature DB >> 31705995

Greater risks of complications, infections, and revisions in the obese versus non-obese total hip arthroplasty population of 2,190,824 patients: a meta-analysis and systematic review.

J R Onggo1, J D Onggo2, R de Steiger3, R Hau4.   

Abstract

BACKGROUND: Obesity is an epidemic, especially in developed countries. This affects the general health of these patients, especially when they are having a major surgical procedure such as total hip arthroplasty (THA). Several articles have described the effects of obesity on THA with varying conclusions. This meta-analysis aims to compare the outcomes, complications, and peri-operative parameters of THA in the obese (BMI≥30 kg/m2) vs non-obese (BMI<30 kg/m2) population as well as a subgroup analysis of morbidly obese (BMI≥40 kg/m2) vs non-obese population.
METHODS: A multi-database search was performed according to PRISMA guidelines. Data from studies assessing the outcomes and complications of THA in the obese and non-obese population were extracted and analyzed.
RESULTS: Sixty-seven studies were included in this meta-analysis, consisting of 581,012 obese and 1,609,812 non-obese patients. Meta-analysis could not be performed on patient reported outcome measures due to heterogeneous reporting methods. Obese patients had a higher risk of all complications (OR = 1.53, 95%CI: 1.30-1.80, P < 0.001), deep infections (OR = 2.71, 95%CI: 2.08-3.53, P < 0.001), superficial infections (OR = 1.99, 95%CI: 1.55-2.55, P < 0.001), dislocations (OR = 1.72, 95%CI: 1.66-1.79, P < 0.001), reoperations (OR = 1.61, 95%CI: 1.40-1.85, P < 0.001), revisions (OR = 1.44, 95%CI: 1.32-1.57, P < 0.001), and readmissions (OR = 1.37, 95%CI: 1.15-1.63, P < 0.001). When sub-group analysis of morbidly obese (BMI≥40 kg/m2) patients was performed, the risks of all these parameters were even greater.
CONCLUSION: Obese and morbidly obese patients are at higher risks of complications post THA than non-obese patients. Surgeons should be aware of these risks in order to counsel patients and adopt prophylactic strategies to reduce these risks where applicable.
Copyright © 2019 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Complications; Morbid obesity; Obesity; Outcomes; Total hip arthroplasty; Total hip replacement

Mesh:

Year:  2019        PMID: 31705995     DOI: 10.1016/j.joca.2019.10.005

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  4 in total

1.  The varus cemented femoral stem in total hip arthroplasty: Predictors, implications and The Femoral Access Ratio.

Authors:  G Sheridan; H Hughes; A Welch-Phillips; P Kenny; G O'Toole; J O'Byrne
Journal:  J Orthop       Date:  2020-12-24

2.  What Is the Risk of THA Revision for ARMD in Patients with Non-metal-on-metal Bearings? A Study from the Australian National Joint Replacement Registry.

Authors:  R N de Steiger; Alesha Hatton; Yi Peng; Stephen Graves
Journal:  Clin Orthop Relat Res       Date:  2020-06       Impact factor: 4.755

Review 3.  EFORT recommendations for off-label use, mix & match and mismatch in hip and knee arthroplasty.

Authors:  Keith Tucker; Klaus-Peter Günther; Per Kjaersgaard-Andersen; Jörg Lützner; Jan Philippe Kretzer; Rob G H H Nelissen; Toni Lange; Luigi Zagra
Journal:  EFORT Open Rev       Date:  2021-11-19

4.  Trends of obesity rates between primary total hip arthroplasty patients and the general population from 2013 to 2020.

Authors:  Nishanth Muthusamy; Thomas Christensen; Vivek Singh; Chelsea Sue Sicat; Joshua C Rozell; Ran Schwarzkopf; Claudette M Lajam
Journal:  Arthroplasty       Date:  2022-09-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.